Financial

The New York City-based company (former MotherKnows) offers its service to academic institutions, linking schools with students and their parents.

The company's framework enables things like payment processing, insurance eligibility checks, referrals, claims submissions and online scheduling.

The company makes a pill-like sensor that is entirely implanted in the user's upper arm from where it can continuously monitor glucose levels.

Existing investors, Runa Capital and Maxfield Capital, provided the capital, bringing the total funding to date to $8.25 million.

The company makes sensors for professional athletes, as well as a platform that analyses data from its sensors to give wearers real-time performance feedback.

The company plans to hire new people, expand to other markets, as well as look for potential acquisition of companies over the next three to six months.

The figure compares to revenues of $114M in the same period last year and represents a Y-o-Y growth of 250%; Fitbit has sold more than 25M devices to date.

The company provides an easy way for direct care (non-clinical) workers to export valuable "red flag" health related events to Case Managers.

The funds will be used to commercialize the second generation of the MoMe Kardia device that transmits a continuous feed of the patient's heart rhythm.

The company, which helps consumers make more informed and cost-effective decisions, will use the funds to accelerate growth and expand its market share.